Vitrectomy, fluid-gas exchange and transforming growth factor--beta-2 for the treatment of traumatic macular holes

Ophthalmology. 1995 Dec;102(12):1840-5. doi: 10.1016/s0161-6420(95)30786-5.

Abstract

Purpose: To evaluate whether vitreous surgery is successful in closing full-thickness traumatic macular holes and whether there is subsequent improvement in visual acuity.

Methods: Twelve eyes from 12 consecutive patients with traumatic macular holes underwent vitrectomy, fluid-gas exchange and instillation of bovine or recombinant transforming growth factor (TGF)-beta-2. Three of four eyes underwent repeat vitrectomy with TGF-beta-2 after the initial procedure failed to close the macular hole.

Results: Eleven (92%) of 12 eyes had closure of the macular hole. Follow-up ranged from 3 to 33 months. Visual acuity improved by 2 or more lines in 8 (67%) of 12 eyes. Six (50%) of 12 eyes improved to 20/40 or better. All 3 eyes that underwent reoperation had successful closure of the macular hole and achieved 2 or more lines of visual improvement.

Conclusion: Treatment of full-thickness traumatic macular holes with vitrectomy, fluid-gas exchange, and TGF-beta-2 may result in successful anatomic closure and visual improvement.

MeSH terms

  • Adolescent
  • Adult
  • Air
  • Child
  • Eye Injuries / complications*
  • Female
  • Fluorescein Angiography
  • Fluorocarbons / administration & dosage*
  • Follow-Up Studies
  • Humans
  • Male
  • Ophthalmic Solutions
  • Recombinant Proteins
  • Reoperation
  • Retina / injuries*
  • Retinal Perforations / etiology
  • Retinal Perforations / therapy*
  • Transforming Growth Factor beta / administration & dosage*
  • Treatment Outcome
  • Visual Acuity
  • Vitrectomy*
  • Wounds, Nonpenetrating / complications*

Substances

  • Fluorocarbons
  • Ophthalmic Solutions
  • Recombinant Proteins
  • Transforming Growth Factor beta
  • perflutren